Status:
COMPLETED
Biomarker Establishment for Superior Treatment of PTSD
Lead Sponsor:
Stanford University
Collaborating Sponsors:
New Mexico VA Healthcare System
Conditions:
PTSD
Eligibility:
All Genders
18-60 years
Brief Summary
The purpose of Biomarker Establishment for Superior Treatment of PTSD is to accelerate research on the discovery of biological, neurological and neuroimaging markers for Post- Traumatic Stress Disorde...
Eligibility Criteria
Inclusion
- Diagnosis of PTSD by VA clinicians and acceptance into PE or CPT treatment as part of the PCT
- Veterans of any era
Exclusion
- MRI safety contraindications
- Active, uncontrolled medical illness
- Acute suicidality
- Current substance dependence
- Current use of thyroid medication or active hyper/hypothyroidism
- Neurological disorder affecting the CNS Seg stroke, epilepsy, tumorW or penetrating head injury
- Use of PRN within 48 hours of the MRI/EEG
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
292 Patients enrolled
Trial Details
Trial ID
NCT03343028
Start Date
September 1 2016
End Date
September 30 2019
Last Update
February 12 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Palo Alto Health Care System (VAPAHCS)
Palo Alto, California, United States, 94304
2
New Mexico VA Health Care System
Albuquerque, New Mexico, United States, 87108